101PD SAMPLEChapter 1 — Patient and Prescription Information (11 of 75 Q) High-yield review. Full doctrine: Treatise Ch. 1. Practice material — not affiliated with the California State Board of Pharmacy or PSI. §1.0 The exam frame - 90 Q (75 scored + 15 invisible pretest) / 120 min / PSI / scaled pass 75 / 45-day retake with reapplication. Outline (eff. 2022-06-01): Areas 23 / 27 / 25. - First-time pass ~64%; overall ~56% (Apr–Sep 2025). CPJE = jurisprudence + CA practice standards; NAPLEX therapeutics assumed. - Read the call first; name the duty; run its elements; answer everything. §1.1 Profiles and records - Profile: identity, allergies, disclosed conditions, full local Rx history. 3-year retention, readily retrievable — the general records rule. - Profile is the substrate of DUR, counseling, error prevention; refusals to disclose are recorded, not invented around. §1.2 Prescription elements - Date; patient name/address; drug, strength, quantity, directions ("as directed" fails); prescriber name/address/category + DEA # on controlled; signature on written. - E-prescribing mandatory (since 2022) with exceptions: veterinarians, tech failure, out-of-state dispensing, enumerated contexts. Pharmacy may fill lawful paper — no duty to police the prescriber's exception. - DEA checksum: (1st+3rd+5th) + 2×(2nd+4th+6th) → last digit = 7th; letters: registrant type + surname initial. Well-formed ≠ genuine — verify the unfamiliar. §1.3 The four screens - Complete → Correct → Authentic → Legal, in order, before fill workflow. - Correction latitude: bounded; controlled cores (drug, quantity, signature) untouchable; every correction documented with source. §1.4 Corresponding responsibility - Pharmacist personally answerable that a controlled Rx serves a legitimate medical purpose in the usual course of practice. Pseudo-prescription = nullity; filling it = unauthorized dispensing. - Red flags: pattern prescribing, trinity (opioid+benzo+carisoprodol), distance, cash, early refills, multi-prescriber/pharmacy, altered/photocopied forms, brand-of-generic insistence. - Resolution sequence: CURES report → prescriber verification → patient dialogue → decide → document. Refusal is lawful; willful blindness never is. §1.5 CURES - Dispensing report: all Schedule II–V within 1 working day, serial numbers included. - Activity reports: the investigation tool; confidential medical information. - Registration mandatory for eligible pharmacists; submission monitoring is the pharmacy's own duty (vendor failure is no defense). §1.6 Security forms - Approved printers; statutory features (watermark, tamper-resistance, quantity check-off, serialized number reported with dispensing). - Forgery protocol: refuse — keep the document — verify — report — document. Never hand it back. §1.7 Prospective DUR - Duplication, drug–drug, drug–disease, dose/duration/route, allergy, misuse — pharmacist- only judgment against the profile; resolve findings before dispensing or counseling. - Allergy alerts are hard stops; override culture is a QA finding. §1.8 Assessment and prescriber authority - CLIA-waived testing = lawful pharmacist practice; technicians collect specimens. - Prescriber atlas: scope-match drug to profession (dentist→dental); NP/PA controlled authority under their frameworks; out-of-state non-controlled fills; verify unfamiliar registrants. §1.9 One-line anchors - 75/120/45/3-years/1-working-day — the chapter's numbers. - Nothing dispenses until the information says so; document, or it didn't happen. §1.10 Verdict table — fill or investigate? Fact pattern Verdict ------ Hospice spouse presents C-II for